Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound.

[1]  M. Riddle,et al.  Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers , 2019, Clinical Diabetes.

[2]  K. Sung,et al.  The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults. , 2008, European journal of endocrinology.

[3]  J. Girona,et al.  Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. , 2007, Atherosclerosis.

[4]  P. Sham,et al.  Serum Adipocyte Fatty Acid–Binding Protein as a New Biomarker Predicting the Development of Type 2 Diabetes , 2007, Diabetes Care.

[5]  A. Xu,et al.  Serum Adipocyte Fatty Acid-Binding Protein Levels Were Independently Associated With Carotid Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[6]  R. Parker,et al.  Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 , 2007, Nature.

[7]  E. Tuzcu,et al.  Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. , 2006, Journal of the American College of Cardiology.

[8]  E. Rimm,et al.  A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Tam,et al.  Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. , 2006, Clinical chemistry.

[10]  K. Feingold,et al.  Adipocyte Fatty Acid–Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[11]  J. Suttles,et al.  The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity , 2005, Journal of Biological Chemistry.

[12]  L. Makowski,et al.  Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. , 2004, The Journal of nutrition.

[13]  G. Frühbeck,et al.  Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases , 2003, Journal of Physiology and Biochemistry.

[14]  M. Woodward,et al.  The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. , 2003, Diabetes care.

[15]  A. Hamsten,et al.  Fatty acid binding protein expression in different human adipose tissue depots in relation to rates of lipolysis and insulin concentration in obese individuals , 2002, Molecular and Cellular Biochemistry.

[16]  Jeffrey B. Boord,et al.  Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis , 2002, Current opinion in lipidology.

[17]  A. Hamsten,et al.  Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals , 2001, Diabetologia.

[18]  Jeffrey B. Boord,et al.  Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis , 2001, Nature Medicine.

[19]  C. Tracy,et al.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[20]  P. Yock,et al.  Intravascular ultrasound: novel pathophysiological insights and current clinical applications. , 2001, Circulation.

[21]  Bruce M. Spiegelman,et al.  Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein , 1996, Science.

[22]  Y. Matsuzawa,et al.  Visceral fat accumulation and cardiovascular disease. , 1995, Obesity research.

[23]  M. Woodward,et al.  The effects of diabetes mellitus on the risks of major cardiovascular diseases and death in the Asia-Pacific region (Journal article) , 2003 .

[24]  S. Hosoda,et al.  Risk factors for coronary heart disease in the Japanese--comparison of the background of patients with acute coronary syndrome in the ASPAC study with data obtained from the general population. Asia-Pacific Collaboration on CHD Risk Factor Intervention study. , 2002, Journal of atherosclerosis and thrombosis.

[25]  Philippe Amouyel,et al.  A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. , 1997 .